R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer
- 16 September 2010
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 31 (1), 99-107
- https://doi.org/10.1111/j.1478-3231.2010.02345.x
Abstract
Background: There is a need for better management strategies to improve the survival and quality of life in patients with biliary tract cancer (BTC). Aim: To assess prognostic factors for survival in a large, non‐selective cohort of patients with BTC. Method: We compared outcomes in 321 patients with a final diagnosis of BTC (cholangiocarcinoma n=237, gallbladder cancer n=84) seen in a tertiary referral cancer centre between 1998 and 2007. Survival according to disease stage and treatment category was compared using log‐rank testing. Cox's regression analysis was used to determine independent prognostic factors. Results: Eighty‐nine (28%) patients underwent a surgical intervention with curative intent, of whom 38% had R0 resections. Among the 321 patients, 34% were given chemo‐ and/or radiotherapy, 14% were palliated with photodynamic therapy (PDT) and 37% with biliary drainage procedures alone. The overall median survival was 9 months (3‐year survival, 14%). R0‐resective surgery conferred the most favourable outcome (3‐year survival, 57%). Although patients palliated with PDT had more advanced clinical T‐stages, their survival was similar to those treated with attempted curative surgery but who had positive resection margins. On multivariable analysis, treatment modality, serum carbohydrate‐associated antigen 19‐9, distant metastases and vascular involvement were independent prognostic indicators of survival. Conclusion: In this large UK series of BTC, palliative PDT resulted in survival similar to those with curatively intended R1/R2 resections. Surgery conferred a survival advantage only in patients with R0 resection margins, emphasising the need for accurate pre‐operative staging.Keywords
This publication has 39 references indexed in Scilit:
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Resection of Hilar CholangiocarcinomaAnnals of Surgery, 2008
- Positron emission tomography (PET) for cholangiocarcinomaHPB, 2008
- CholangiocarcinomaAnnals of Surgery, 2007
- Palliation for suspected unresectable hilar cholangiocarcinomaEuropean Journal of Surgical Oncology, 2007
- Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trialsBritish Journal of Cancer, 2007
- Surgical and Palliative Management and Outcome in 184 Patients With Hilar CholangiocarcinomaAnnals of Surgery, 2006
- CholangiocarcinomaThe Lancet, 2005
- Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UKEuropean Journal of Surgical Oncology, 2005
- Results of Surgical Resection for Patients With Hilar Bile Duct CancerAnnals of Surgery, 2003